Skip to main content

Kimura disease: review of the literature

Buy Article:

$43.00 plus tax (Refund Policy)


Kimura disease (KD) is a rare, chronic inflammatory disease of unknown cause and is characterized by painless s.c. swellings and lymphadenopathy commonly affecting the head and neck region. Much therapeutics has been used to treat KD, but is not satisfactory because of frequent relapse. Imatinib has been reported previously to be useful for treatment of hypereosinophilic syndrome and may work by selectively blocking protein-tyrosine kinases, such as platelet-derived growth factor receptor, and c-Kit. We carried out immunohistochemical examination of platelet-derived growth factor receptor-α and c-Kit in tissues from patients with KD. The results were positive and suggested that Imatinib might be an effective drug for the treatment of the disease. We have also briefly reviewed the epidemiology, aetiology, clinical manifestations, laboratory and pathological examinations, differential diagnoses, treatment and prognosis of KD in this manuscript.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Imatinib; Kimura disease; eosinophilia; immunohistochemistry; protein-tyrosine kinase

Document Type: Research Article

Affiliations: 1: Beijing Di-tan Hospital, Beijing, China 2: Pathology 3: Departments of Infectious Diseases 4: Nephrology 5: Surgery, The Third Affiliated Hospital to Wenzhou Medical College, Wenzhou, Zhejiang

Publication date: 01 August 2008

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more